IPF

FAQs

• At what age is idiopathic pulmonary fibrosis commonly diagnosed?

  Idiopathic pulmonary fibrosis is usually diagnosed in older adults. The condition is more common in individuals above 50 years of age. Risk may increase with smoking history, long-term exposure to irritants, or certain genetic and environmental factors. 

• Is an IPF diagnosis painful or invasive?

  IPF diagnosis usually begins with non-invasive tests such as imaging scans and lung function assessments. Some procedures, such as bronchoscopy or lung biopsy, may be recommended in selected cases to confirm the diagnosis and assess lung scarring.

• What are the common IPF causes?

  Although exact IPF causes are often difficult to identify because the disease frequently develops without a clear trigger. However, factors such as smoking, environmental dust exposure, certain medications, and autoimmune conditions may increase the risk of lung scarring.

• Can IPF symptoms worsen over time?

  Yes, IPF symptoms may gradually worsen as lung scarring progresses. Individuals may experience increasing breathlessness, fatigue, and reduced tolerance for physical activity. Disease progression varies between individuals, and regular medical monitoring is usually recommended.

• What treatment options are used to manage the condition?

  IPF treatment focuses on slowing disease progression and relieving breathing difficulties. Management may include antifibrotic medications, oxygen therapy, pulmonary rehabilitation, and supportive care. In advanced cases, lung transplantation may be considered.